Melanoma trials in Austria
6 of 10 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 13 November 2026. Ask the study team whether a trial fits you.
- Phase 4Taking peopleDabrafenib and/or Trametinib Rollover Study
- Where
- Innsbruck
- Age
- 18 years to 100 years
- People
- 100 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT03340506 · EU 2023-509318-13-00 - Phase 2/3Taking peopleSafety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma.
- Where
- Graz
- Age
- 18 years and over
- People
- 740 worldwide
- Run by
- Eikon Therapeutics
See details and how to joinNCT06697301 · EU 2024-512659-19-00 - Phase 2Not yet taking people in AustriaPHOENIX - ECP: Extracorporeal PHotopheresis for immune-related cOlitis and/or hEpatitis in advanced melaNoma with inadequate response to steroId eXposure
- Where
- Graz, Salzburg, Vienna
- Age
- 18 years and over
- People
- 46 worldwide
- Run by
- Therakos Europe Limited
See details and how to join2026-526261-14-00 - Phase 3Taking peopleNeoadjuvant Darovasertib in Primary Uveal Melanoma
- Where
- Graz, Innsbruck, Vienna
- Age
- 18 years and over
- People
- 520 worldwide
- Run by
- IDEAYA Biosciences
See details and how to joinNCT07015190 · EU 2025-522387-32-00 - Phase 3Taking peopleTebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)
- Where
- Graz, Linz, Salzburg, Vienna
- Age
- 18 years and over
- People
- 540 worldwide
- Run by
- Immunocore Ltd
See details and how to joinNCT05549297 · EU 2022-502732-39-00 - Phase 3Taking peopleIMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301)
- Where
- Graz, Pölten, Salzburg, Vienna
- Age
- 18 years and over
- People
- 680 worldwide
- Run by
- Immunocore Ltd
See details and how to joinNCT06112314